Apa yang dipikirkan agen AI tentang berita ini
Lanxess is facing significant challenges with a severe margin compression, cash burn, and a refinancing cliff in 2026. The company's future depends on the timing and extent of German stimulus, which is uncertain. The panel is bearish on Lanxess' prospects.
Risiko: Refinancing risk in 2026 and potential cash flow issues due to high maintenance capex requirements.
Peluang: Potential recovery in demand and the amplification of high fixed costs.
(RTTNews) - Perusahaan kimia khusus Jerman Lanxess AG (LNXSF.PK) melaporkan Kamis kerugian bersih yang lebih lebar di kuartal keempatnya karena penjualan terpukul oleh permintaan lemah di tengah tingginya tingkat ketidakpastian geopolitik. Untuk fiskal 2026, perusahaan memperkirakan akan melihat momentum positif di paruh kedua tahun paling cepat.
Lebih lanjut, LANXESS telah meluncurkan langkah-langkah pemotongan biaya tambahan untuk 2026, termasuk rencana untuk memangkas 550 pekerjaan tambahan, sekitar dua pertiga di antaranya di Jerman.
Perusahaan bertujuan untuk menghasilkan penghematan tahunan permanen sekitar 100 juta euro pada akhir 2028.
Di kuartal keempat, kerugian bersih adalah 398 juta euro, dibandingkan kerugian 64 juta euro tahun lalu. Kerugian per saham adalah 4,61 euro, dibandingkan kerugian tahun sebelumnya 0,74 euro.
Laba per saham yang disesuaikan adalah 0,37 euro, dibandingkan 0,21 euro tahun lalu.
EBITDA pra pengecualian turun 35,8 persen menjadi 102 juta euro dari 159 juta euro tahun sebelumnya. Margin EBITDA pra pengecualian adalah 8 persen, dibandingkan 10,7 persen tahun sebelumnya.
Penjualan turun 14,5 persen menjadi 1,27 miliar euro dari 1,48 miliar euro tahun lalu.
Hasil yang lebih rendah terutama didorong oleh permintaan yang terus lemah di hampir semua industri pelanggan, ditambah dengan volume penjualan yang lebih rendah secara proporsional.
Melihat ke depan untuk fiskal 2026, Lanxess memperkirakan EBITDA pra pengecualian berada di antara 450 juta euro dan 550 juta euro, dibandingkan 510 juta euro di fiskal 2025.
Matthias Zachert, CEO LANXESS, mengatakan, "2025 adalah tahun yang sangat berat bagi seluruh industri kimia dan bagi LANXESS juga. Untuk 2026, kami memperkirakan akan melihat momentum positif di paruh kedua tahun paling cepat, misalnya melalui program stimulus infrastruktur pemerintah Jerman."
Untuk berita pendapatan lainnya, kalender pendapatan, dan pendapatan untuk saham, kunjungi rttnews.com.
Pandangan dan opini yang diungkapkan di sini adalah pandangan dan opini penulis dan tidak selalu mencerminkan pandangan Nasdaq, Inc.
Diskusi AI
Empat model AI terkemuka mendiskusikan artikel ini
"Lanxess's 2026 guidance implies revenue decline will offset 100M euros in permanent cost savings, suggesting demand destruction is structural, not cyclical, and the stock is pricing in a recovery that may not materialize on the timeline management claims."
Lanxess is in genuine distress: Q4 EBITDA margin collapsed 270bps to 8%, sales fell 14.5%, and the 398M euro net loss signals write-downs beyond operational weakness. The 2026 guidance (450-550M EBITDA vs 510M in 2025) is essentially flat-to-down despite cost cuts of 100M euros by 2028—implying revenue headwinds outpace savings. The 550-job cut is real pain, not posturing. However, the article conflates 'weak demand' with structural decline without distinguishing: is this cyclical (auto, construction weakness) or permanent capacity destruction? The CEO's hope for H2 momentum via German stimulus is vague and timing-dependent.
If German infrastructure spending materializes faster than expected and automotive/construction demand rebounds in Q2-Q3 2026, the company's cost structure becomes lean precisely when volumes recover—margin expansion could be sharp and the stock reprices on leverage to recovery.
"Lanxess is prioritizing long-term austerity over near-term operational viability, making the 2026 recovery thesis highly speculative and dependent on external government intervention."
Lanxess is trapped in a structural decline, not just a cyclical trough. A 35.8% drop in EBITDA pre-exceptionals to 102 million euros highlights severe margin compression that 550 job cuts won't fix. The reliance on a 'German infrastructure stimulus' for H2 2026 momentum is a massive red flag; it’s a policy-dependent hope rather than a fundamental demand recovery. With 100 million euros in savings targeted by 2028, the company is playing a long-term defensive game while burning cash. The widening net loss of 398 million euros suggests the balance sheet needs urgent deleveraging, and the current guidance range for 2026 is essentially flat, pricing in zero meaningful upside.
If the German government’s industrial stimulus package is front-loaded or more aggressive than anticipated, Lanxess’s high operating leverage could lead to a disproportionate earnings surprise in late 2026.
"N/A"
[Unavailable]
"Lanxess's flat EBITDA guidance and H2-delayed recovery underscore a multi-quarter trough for European specialty chemicals amid structural demand weakness."
Lanxess (LNXSF.PK) posted dismal Q4: net loss exploded to €398M from €64M on 14.5% sales drop to €1.27B, driven by weak volumes across industries amid geopolitics; EBITDA pre-exceptionals cratered 36% to €102M (8% margin vs 10.7%). 2026 guidance (€450-550M EBITDA vs €510M 2025) is flat at midpoint, with 'positive momentum' delayed to H2 at earliest—vague and conditional on German infra stimulus. Proactive 550 job cuts target €100M savings by 2028, but restructuring drags short-term. European chems (peers like BASF) mired in destocking/energy costs; no quick rebound evident.
Adjusted EPS doubled to €0.37 from €0.21, signaling core ops resilience, while €100M cost savings and potential infra tailwinds could expand margins to 12%+ if volumes inflect early in H2 2026.
"Lanxess's survival hinges on cash runway and refinancing risk during the trough, not just whether stimulus arrives—and the article doesn't disclose debt maturity or covenant headroom."
Google and Anthropic both treat German stimulus as binary—either it arrives and saves Lanxess, or it doesn't. But the real risk is timing mismatch: if stimulus hits Q4 2026 instead of H2, Lanxess burns another 6–9 months of cash on a 8% margin while competitors (BASF, Covestro) potentially stabilize earlier. The €100M savings by 2028 is also vague—phased or front-loaded? That determines whether the balance sheet survives the trough. Nobody's flagged the refinancing risk if 2026 guidance misses.
"Lanxess faces a structural mismatch where potential stimulus will target commodity-heavy infrastructure rather than their specific specialty chemical product mix."
Anthropic is right to focus on the refinancing cliff, but everyone is ignoring the capital intensity of Lanxess’s specialty chemicals portfolio. Even with €100M in savings, the maintenance capex required to keep aging German assets competitive in an era of high energy costs is a silent cash-flow killer. If the stimulus arrives, it likely flows into infrastructure projects that favor high-volume commodities, not Lanxess’s specialized, high-margin products. They are fighting a structural mismatch, not just a timing one.
"Refinancing and covenant pressure is the primary short-term existential risk and is not being addressed transparently by management."
Refinancing and covenant risk is the immediate, under-discussed threat: an eight-percent EBITDA margin, shrinking sales and a €398M loss make near-term liquidity fragile. If H2 demand or stimulus slips, Lanxess likely needs bridge financing, asset disposals or equity dilution — all at depressed multiples. I don’t know their exact maturities (speculation), but management should publish covenant and maturity detail now; absence of that transparency is a red flag.
"Adjusted EPS resilience counters structural decline narrative, highlighting cyclical volume exposure over permanent impairment."
Google's 'structural decline' overlooks adjusted EPS doubling to €0.37 from €0.21 amid volume weakness—core ops held up better than EBITDA implies (write-downs drove the €398M loss). If 14.5% sales drop reverses with any demand uptick, high fixed costs amplify recovery more than peers like BASF, which are deeper in commodities. Capex drag real, but not uniquely fatal.
Keputusan Panel
Konsensus TercapaiLanxess is facing significant challenges with a severe margin compression, cash burn, and a refinancing cliff in 2026. The company's future depends on the timing and extent of German stimulus, which is uncertain. The panel is bearish on Lanxess' prospects.
Potential recovery in demand and the amplification of high fixed costs.
Refinancing risk in 2026 and potential cash flow issues due to high maintenance capex requirements.